Myokardia investor relations
WebMay 11, 2024 · MyoKardia anticipates using net proceeds from the offering, together with its existing cash, cash equivalents and short-term and long-term investments, to support the regulatory approval process... WebApr 10, 2024 · RADNOR, PA / ACCESSWIRE / April 10, 2024 / BM Technologies, Inc. (NYSE American:BMTX), one of the largest digital banking platforms and Banking-as-a-Service (BaaS) providers, was selected as a winner in the 2024 FinTech Breakthrough Awards in the Best Banking Infrastructure Software award category. The Fintech Breakthrough Awards …
Myokardia investor relations
Did you know?
WebMYOKARDIA, INC. : Press releases relating to MYOKARDIA, INC. Investor relations Deutsche Boerse AG: 9MK Deutsche Boerse AG WebJul 21, 2024 · MyoKardia Contacts Michelle Corral Executive Director, Corporate Communications and Investor Relations MyoKardia, Inc. 650-351-4690 …
WebOct 29, 2015 · What: MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and … WebMyokardia, Inc. * 8 Principals See who the company's key decision makers are 83 Contacts Reach the right people with access to detailed contact information. Corporate Relations Get the big picture on a company's affiliates and who they do business with. 9 See similar companies for insight and prospecting. Start Your Free Trial
WebNov 16, 2024 · 2024. Transcript : MyoKardia, Inc. Presents at Barclays Global Healthcare Conference 2024, Mar-16-2024 01:35 PM. CI. 2024. Bristol Myers Squibb and Celgene … WebApr 30, 2015 · MyoKardia has raised a total of $98M in funding over 4 rounds. Their latest funding was raised on Apr 30, 2015 from a Series B round. MyoKardia is registered under …
WebApr 30, 2015 · MyoKardia is funded by 7 investors. BridgeBio Pharma and Cowen Group are the most recent investors. Funding Rounds Number of Funding Rounds 4 Total Funding Amount $98M MyoKardia has raised a total of $98M in funding over 4 rounds. Their latest funding was raised on Apr 30, 2015 from a Series B round. Which funding types raised the …
WebNov 4, 2024 · Senior Director, Corporate Communications and Investor Relations MyoKardia, Inc. 650-351-4690 [email protected] . Hannah Deresiewicz (investors) Stern Investor … delaware city schools special needs preschoolWebMay 10, 2024 · MyoKardia, Inc. (NASDAQ:MYOK) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Michelle Corral - Senior Director of Corporate Communications and Investor Relations delaware city tax formWeb28 April 2024 (Friday) Time: 4:30 pm – 5:30 pm. Venue: Online via Zoom. Language: English. Outline: Our speakers will present their views and experience on what elements of information would attract potential investors in this stagnating market and also share examples of investment stories which has helped to catch investor’s eyeballs (or ... fentanyl veterinary medicineWebJun 22, 2024 · Contacts Michelle Corral MyoKardia, Inc. 650-351-4690 [email protected] Hannah Deresiewicz (investors) Stern Investor Relations, Inc. 212-362-1200 [email protected] Julie Normant (media) W2O 628-213-3754 [email protected] delaware city tax paymentWebstockholders of MyoKardia free of charge at www.myokardia.com or by contacting MyoKardia at [email protected], telephone number 650-351-4690. In addition to the offer … fentanyl users photosWebYou may read and copy any reports, statements or other information filed by Bristol Myers Squibb or MyoKardia at the SEC public reference room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. Bristol Myers Squibb’s and MyoKardia’sfilings with the SEC delaware city schools scheduleWebNASDAQ INVESTOR RELATIONS News & Events Press Releases Events & Presentations Stock Information Stock Quote & Chart Historic Stock Lookup Investment Calculator Analyst Coverage Earnings... delaware city water bill